Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 Nov;80(3):498–501.

Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.

R A Smerdon 1, M Peakman 1, M J Hussain 1, D Vergani 1
PMCID: PMC1422211  PMID: 8288322

Abstract

The aim of this study was to investigate whether lymphocyte vaccination can prevent diabetes occurring in the non-obese diabetic (NOD) mouse, an animal model of human insulin-dependent diabetes mellitus (IDDM). The lymphocyte vaccine was composed of lymphocytes isolated from the spleens of diabetic NOD mice, activated in vitro using concanavalin A (Con A) and rendered immunogenic using glutaraldehyde treatment. These cells were used to vaccinate mice at 6 weeks with boosters at weeks 10, 14 and 18. The animals were then monitored for signs of diabetes until week 30. Twenty-eight NOD mice (11 male, 17 female) were T-lymphocyte vaccinated while 35 littermates (14 male, 21 female) were sham vaccinated with the vaccine carrier, as control mice. The percentage of mice remaining non-diabetic was 50% in the T-lymphocyte-vaccinated group compared with 20% in control mice (P < 0.05). When the results were divided according to sex of the mouse the percentage of female NOD mice remaining non-diabetic was 47.1% in the T-lymphocyte-vaccinated group compared to only 9.4% in the controls (P < 0.01), while in the males there was no significant difference between the groups. These results suggest that T-lymphocyte vaccination can prevent diabetes in NOD mice and that it has its greatest effect in females. The therapy is apparently safe and its efficacy indicates that it may be of value in prediabetes in man.

Full text

PDF
498

Images in this article

500Figure 2
on p.500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castaño L., Eisenbarth G. S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol. 1990;8:647–679. doi: 10.1146/annurev.iy.08.040190.003243. [DOI] [PubMed] [Google Scholar]
  2. Cohen I. R. Physiological basis of T-cell vaccination against autoimmune disease. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 2):879–884. doi: 10.1101/sqb.1989.054.01.102. [DOI] [PubMed] [Google Scholar]
  3. Feldmann M., June C. H., McMichael A., Maini R., Simpson E., Woody J. N. T-cell-targeted immunotherapy. Immunol Today. 1992 Mar;13(3):84–85. doi: 10.1016/0167-5699(92)90146-X. [DOI] [PubMed] [Google Scholar]
  4. Hafler D. A., Cohen I., Benjamin D. S., Weiner H. L. T cell vaccination in multiple sclerosis: a preliminary report. Clin Immunol Immunopathol. 1992 Mar;62(3):307–313. doi: 10.1016/0090-1229(92)90108-z. [DOI] [PubMed] [Google Scholar]
  5. Kingsley G., Panayi G., Lanchbury J. Immunotherapy of rheumatic diseases--practice and prospects. Immunol Today. 1991 Jun;12(6):177–179. doi: 10.1016/0167-5699(91)90048-X. [DOI] [PubMed] [Google Scholar]
  6. Lider O., Karin N., Shinitzky M., Cohen I. R. Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4577–4580. doi: 10.1073/pnas.84.13.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I. R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 1988 Jan 8;239(4836):181–183. doi: 10.1126/science.2447648. [DOI] [PubMed] [Google Scholar]
  8. Lohse A. W., Cohen I. R. Mechanisms of resistance to autoimmune disease induced by T-cell vaccination. Autoimmunity. 1991;9(2):119–121. doi: 10.3109/08916939109006747. [DOI] [PubMed] [Google Scholar]
  9. Lohse A. W., Mor F., Karin N., Cohen I. R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science. 1989 May 19;244(4906):820–822. doi: 10.1126/science.2471264. [DOI] [PubMed] [Google Scholar]
  10. Maron R., Zerubavel R., Friedman A., Cohen I. R. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol. 1983 Nov;131(5):2316–2322. [PubMed] [Google Scholar]
  11. Mor F., Lohse A. W., Karin N., Cohen I. R. Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen. J Clin Invest. 1990 May;85(5):1594–1598. doi: 10.1172/JCI114610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tochino Y. The NOD mouse as a model of type I diabetes. Crit Rev Immunol. 1987;8(1):49–81. [PubMed] [Google Scholar]
  13. Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 1986 Aug;35(8):855–860. doi: 10.2337/diab.35.8.855. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES